Crispr Therapeutics shares tumble after significant earnings miss
La-Z-Boy Inc (NYSE:LZB). stock reached a 52-week low, trading at $35.13, reflecting ongoing challenges in the market. According to InvestingPro data, the company maintains strong financial health with a current ratio of 1.91, indicating liquid assets exceed short-term obligations. Over the past year, the company’s stock has experienced a decline of 16.42%, highlighting a period of volatility and adjustment for the furniture manufacturer. Despite market pressures, La-Z-Boy has maintained dividend payments for 14 consecutive years, with a current dividend yield of 2.45%. The drop to this new low underscores the broader pressures facing the industry, including supply chain disruptions and fluctuating consumer demand. As La-Z-Boy navigates these challenges, investors will be closely monitoring its strategies to regain momentum and stabilize its financial performance. The company currently appears undervalued based on InvestingPro’s Fair Value analysis, with analysts maintaining a moderate buy consensus and projecting profitability for the upcoming year.
In other recent news, La-Z-Boy has reported its fourth-quarter earnings for fiscal year 2025, revealing an adjusted earnings per share (EPS) of $0.92, which missed the forecasted $0.98. However, the company’s revenue surpassed expectations, reaching $571 million, a 2.29% surprise over the anticipated $558.21 million. La-Z-Boy also announced the acquisition of 15 dealer stores and four warehouses from Atlanta Furniture Galleries, LLC, owned by Tom and Amy DeGoey. This acquisition is estimated by KeyBanc to potentially add $0.10 annually to earnings per share. Despite this positive development, La-Z-Boy has lowered its fiscal first-quarter outlook, anticipating sales and adjusted operating margin to be at the low end of its previously issued guidance. The company cites an increasingly challenging consumer and macro environment as the reason for this adjustment. Sidoti has maintained its Neutral rating with a $46.00 price target on La-Z-Boy, while KeyBanc has reiterated its Overweight rating with the same price target. These recent developments highlight the mixed financial landscape La-Z-Boy is navigating.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.